Harvard Medical School

Hormonal changes associated with menopause include vasomotor symptoms (hot flashes, night sweats), sleep disturbance, depression and anxiety. Although hormone therapy is effective for treating menopause-related symptoms, most are associated with negative side effects, prompting researchers to...

Psychedelics startups are being increasingly funded by private placements these days. This time, the biotech company led by expert researchers, clinicians and drug developers from Massachusetts General Hospital and Harvard Medical School, Sensorium Therapeutics, has closed a $30 million Series...

New research by the University of Cambridge, U.K, showed that "adult and adolescent cannabis users are no more likely than non-users to lack motivation or be unable to enjoy life’s pleasure." According to researchers, "there is no scientific basis for the stereotype often...

At the American Psychological Association annual meeting in New Orleans, recognized doctors who participated from a medical cannabis panel discussion, expressed that the evidence on the use of medical marijuana is limited, and recommended clinicians should be cautious when discussing...

While the Internet appears to have all the answers we need, it is more important than ever to know how to use it, where to look for information, and more importantly, to confirm if it is indeed true. Mark Twain is attributed as saying: "A lie can travel halfway around the...

Atai Life Sciences t announced on Tuesday a new research collaboration with Massachusetts General Hospital, the largest teaching hospital of Harvard Medical School. The partnership will help advance the hospital’s Center for Neuroscience of Psychedelics, a recently-launched center...

Versión en Español en El Planteo. Gallup has estimated that at least 33 million adults in the United States are marijuana users right now — although government studies say the figure stands closer to 20 million. No matter what the actual number is, the fact is that a lot of people either...

In a move that could cost CVS Caremark (NYSE: CVS) $2 billion annually, the country’s second-largest drugstore chain said it would phase out cigarettes, cigars, and chewing tobacco by October 1. The change affects the chain’s more than 7,600 drugstores nationwide and was part of an overall...

Merck & Co. Inc. (NYSE: MRK) agreed to settle shareholder lawsuits related to its withdrawn Vioxx painkiller by paying $12.2 million in legal fees, appointing a Chief Medical Officer and promising to improve its drug safety procedures. Vioxx was withdrawn by Merck & Co. in 2004 after a...